Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 03:59PM ET
0.3300
Dollar change
-0.0400
Percentage change
-10.81
%
Index- P/E- EPS (ttm)-13.10 Insider Own3.90% Shs Outstand2.96M Perf Week-41.18%
Market Cap0.98M Forward P/E- EPS next Y-0.60 Insider Trans0.00% Shs Float2.85M Perf Month-57.06%
Income-13.93M PEG- EPS next Q-0.92 Inst Own8.53% Short Float7.79% Perf Quarter-82.81%
Sales19.97M P/S0.05 EPS this Y93.57% Inst Trans- Short Ratio0.30 Perf Half Y-84.29%
Book/sh-5.45 P/B- EPS next Y89.86% ROA-94.90% Short Interest0.22M Perf Year-97.01%
Cash/sh0.97 P/C0.34 EPS next 5Y- ROE-2554.11% 52W Range0.20 - 12.25 Perf YTD-83.08%
Dividend Est.- P/FCF- EPS past 5Y49.72% ROI- 52W High-97.31% Beta1.42
Dividend TTM- Quick Ratio0.44 Sales past 5Y153.23% Gross Margin57.75% 52W Low65.00% ATR (14)0.11
Dividend Ex-Date- Current Ratio0.57 EPS Y/Y TTM98.25% Oper. Margin-113.70% RSI (14)23.31 Volatility26.92% 15.75%
Employees22 Debt/Eq- Sales Y/Y TTM137.70% Profit Margin-69.73% Recom3.00 Target Price5.00
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q98.98% Payout- Rel Volume0.40 Prev Close0.37
Sales Surprise-1.58% EPS Surprise20.11% Sales Q/Q121.92% EarningsMar 28 BMO Avg Volume734.85K Price0.33
SMA20-49.25% SMA50-68.18% SMA200-83.20% Trades Volume293,405 Change-10.81%
Date Action Analyst Rating Change Price Target Change
Apr-07-21Resumed RBC Capital Mkts Outperform $8
Apr-12-19Resumed Janney Buy $4
Nov-29-18Initiated Maxim Group Buy $3
Dec-26-17Downgrade William Blair Outperform → Mkt Perform
Dec-26-17Downgrade Janney Buy → Neutral
Oct-02-17Resumed H.C. Wainwright Buy $10
Sep-14-17Reiterated RBC Capital Mkts Outperform $8 → $10
Jul-19-17Initiated H.C. Wainwright Buy $10
Jan-08-16Initiated Cantor Fitzgerald Buy
Apr-02-15Initiated FBR Capital Outperform $17
Today 08:05AM
Mar-25-24 04:30PM
Mar-24-24 03:54PM
Mar-21-24 06:35AM
Mar-20-24 08:15AM
07:31AM Loading…
Mar-13-24 07:31AM
Mar-12-24 10:20AM
Feb-22-24 09:01AM
07:57AM
Feb-15-24 04:30PM
Jan-25-24 04:40AM
Jan-23-24 09:29AM
Dec-12-23 08:01AM
Nov-22-23 09:00AM
Nov-10-23 10:20AM
08:17AM Loading…
Nov-09-23 08:17AM
08:05AM
Oct-26-23 08:05AM
Oct-04-23 04:30PM
Sep-28-23 04:19PM
09:00AM
Sep-22-23 09:38AM
Sep-05-23 08:05AM
Aug-17-23 09:00AM
Aug-11-23 09:35AM
Aug-09-23 08:14AM
08:05AM
Jul-26-23 08:30AM
Jul-19-23 09:00AM
Jul-18-23 09:00AM
09:15AM Loading…
Jul-11-23 09:15AM
Jul-05-23 09:00AM
Jul-03-23 09:00AM
Jun-30-23 09:00AM
Jun-28-23 09:00AM
Jun-27-23 03:36PM
Jun-26-23 08:01AM
Jun-23-23 12:05PM
Jun-15-23 04:05PM
Jun-14-23 11:29AM
Jun-13-23 04:05PM
May-25-23 04:05PM
May-22-23 08:00PM
May-12-23 06:29AM
May-11-23 04:43PM
04:05PM
May-08-23 08:00AM
Apr-28-23 08:01AM
Apr-26-23 09:01AM
Apr-10-23 04:30PM
Apr-05-23 05:30AM
Mar-27-23 02:25AM
Mar-23-23 12:49PM
Mar-22-23 04:05PM
Mar-21-23 09:05AM
Feb-27-23 08:31AM
Feb-20-23 09:40AM
Feb-15-23 08:00AM
Feb-09-23 08:00AM
Feb-03-23 09:40AM
Feb-01-23 08:01AM
Jan-26-23 04:30PM
Jan-20-23 08:45AM
Jan-18-23 09:40AM
Jan-09-23 07:00AM
Dec-21-22 09:05AM
Dec-01-22 08:30AM
Nov-15-22 08:15AM
Nov-07-22 04:05PM
Oct-26-22 08:30AM
08:00AM
Oct-21-22 11:00AM
Oct-07-22 04:25PM
Sep-06-22 08:30AM
Aug-11-22 09:30PM
04:05PM
Jul-28-22 08:05AM
Jul-26-22 03:47PM
Jul-14-22 08:45AM
Jul-12-22 02:33PM
10:55AM
08:05AM
Jul-08-22 08:05AM
Jul-06-22 05:16PM
Jul-01-22 09:20AM
Jun-28-22 09:58AM
May-17-22 08:01AM
May-13-22 12:00AM
May-12-22 04:05PM
May-05-22 05:01PM
May-03-22 07:30AM
Apr-26-22 10:46AM
08:00AM
Apr-19-22 09:53AM
Apr-14-22 07:30AM
Apr-11-22 07:05AM
Apr-07-22 07:30AM
Mar-31-22 07:30AM
Mar-30-22 11:00PM
05:25PM
Agile Therapeutics, Inc. is a healthcare company, which engages in the development and commercialization of transdermal patches. Its lead product candidate, Twirla, also known as AG200-15, is an investigational low-dose, non-daily prescription contraceptive. The company was founded by Chien Te Yen on December 22, 1997 and is headquartered in Princeton, NJ.